ARVIS® Shoulder
Insight Medical Systems, Inc. • Neurology • 04/29/2024
Device Purpose
The ARVIS® Shoulder is an advanced surgical navigation system intended to enhance the accuracy of total shoulder arthroplasty by assisting surgeons with intraoperative measurements and implant positioning. It achieves this through a combination of CT-based preoperative planning, utilizing AI-driven image segmentation and landmarking algorithms, and real-time intraoperative tracking of instruments relative to the patient's anatomy.
Summary
The ARVIS® Shoulder is a computer-controlled surgical navigation system designed to provide intra-operative measurements to surgeons, aiding in the selection and positioning of orthopedic implant components specifically for total shoulder arthroplasty. This system integrates software, electronic hardware worn by the surgeon on the head and waist, and surgical instruments to intraoperatively track tools and locate anatomical structures. The workflow relies on preoperative CT-based reconstruction of the patient's shoulder anatomy and a detailed preoperative plan, which then guides the surgeon in navigating and positioning shoulder instruments and implants, specifically for use with the Enovis AltiVate implant system. The system's preoperative planning platform employs AI-based automatic image segmentation and landmarking algorithms. These algorithms were trained using a dataset of 240 CT scans and validated on a separate test dataset of 60 CT scans from patients undergoing shoulder joint replacement. Non-clinical performance testing, including positional accuracy (ASTM F2554), accuracy after mechanical disturbances (ASTM F3107), benchtop accuracy, cadaveric accuracy, and cadaver validation, was conducted. The software, particularly the AI algorithms, underwent verification and validation, demonstrating that the automatic segmentation (for scapula and humerus) and landmarking (for glenoid center, trigonum, inferior point, medial/lateral epicondyles, and neck plane) met predefined acceptance criteria based on metrics like Dice Similarity Coefficient, Mean Absolute Distance, Hausdorff Distance, Euclidean Distance, and Angular Separation.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the AI-based automatic image segmentation and landmarking algorithms vary with different CT scanner manufacturers and imaging protocols not explicitly included in the training/testing datasets?; What is the reported accuracy and precision of implant placement when using the ARVIS® Shoulder system compared to traditional techniques or other navigation systems in a clinical setting, beyond the benchtop and cadaveric studies?; Are there any specific patient anatomical variations or pathological conditions of the shoulder (e.g., severe bone loss, previous fractures) that might limit the accuracy or applicability of the ARVIS® Shoulder system's navigation and AI algorithms?; What is the learning curve for surgeons to become proficient with the ARVIS® Shoulder system, particularly regarding the preoperative planning and intraoperative navigation components?; Given its reliance on the Enovis AltiVate implant system, what are the technical challenges and validation requirements for potentially expanding compatibility with other shoulder implant systems in the future?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly